Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2016 April;57(2) > The Journal of Cardiovascular Surgery 2016 April;57(2):172-7

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

THE JOURNAL OF CARDIOVASCULAR SURGERY

A Journal on Cardiac, Vascular and Thoracic Surgery


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,632


eTOC

 

THORACIC AND ABDOMINAL AORTA  20 YEARS EVC: MANAGEMENT OF ARTERIAL DISEASES


The Journal of Cardiovascular Surgery 2016 April;57(2):172-7

language: English

Precision medical and surgical management for thoracic aortic aneurysms and acute aortic dissections based on the causative mutant gene

Dianna MILEWICZ , Ellen HOSTETLER, Stephanie WALLACE, Lauren MELLOR-CRUMMEY, Limin GONG, Hariyadarshi PANNU, Dong C. GUO, Ellen REGALADO

Division of Medical Genetics, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA


PDF  


Almost one-quarter of patients presenting with thoracic aortic aneurysms (TAAs) or acute aortic dissections (TAADs) have an underlying mutation in a specific gene. A subset of these patients will have systemic syndromic features, for example, skeletal features in patients with Marfan Syndrome. It is important to note that the majority of patients with thoracic aortic disease will not have these syndromic features but many will have a family history of the disease. The genes predisposing to these thoracic aortic diseases are inherited in an autosomal dominant manner, and thirteen genes have been identified to date. As the clinical phenotype associated with each specific gene is defined, the data indicate that the underlying gene dictates associated syndromic features. More importantly, the underlying gene also dictates the aortic disease presentation, the risk for dissection at a given range of aortic diameters, the risk for additional vascular diseases and what specific vascular diseases occur associated with the gene. These results lead to the recommendation that the medical and surgical management of these patients be dictated by the underlying gene, and for patients with mutations in ACTA2, the specific mutation in the gene.

top of page

Publication History

Cite this article as

Corresponding author e-mail

Dianna.M.Milewicz@uth.tmc.edu